Absorption

Absorption is the process by which a substance moves from its point of entry — the gut wall, nasal mucosa, lung tissue, or skin — into the bloodstream, making it available to act on the brain and body. It is the first phase of pharmacokinetics, the field concerned with how the body handles a drug over time.

The route of administration determines where absorption happens and shapes everything that follows: onset speed, intensity, and how much of the original dose ever reaches its intended site of action. Two people taking the same substance by different routes are, in a meaningful pharmacological sense, having different experiences.

How it works · its role

Most substances cross biological membranes by passive diffusion — moving from an area of higher concentration to lower, without requiring energy. Lipid-soluble molecules pass through fatty cell membranes readily; substances that are more water-soluble or that carry an electrical charge at body pH cross more slowly or less completely.

A major variable for oral substances is the first-pass effect. After passing through the gut wall, a substance travels via the portal vein to the liver before entering general circulation. Liver enzymes can break down a portion of it there, before it has had a chance to act. Inhalation and intravenous routes bypass this step entirely; sublingual and rectal routes do so partially — which is why the same dose delivered by different routes can produce meaningfully different effects.

Other factors that shape how efficiently a substance is taken up include local pH, blood flow to the site, surface area available for transfer, and whether food is present in the gut.

Relevance to substances & effects

Route of administration is the most direct way absorption shapes a substance's subjective effects. Inhaled or vaporized substances reach the bloodstream through the lungs' dense capillary network within seconds, producing rapid, pronounced onset. Oral substances must traverse the gut lining and survive first-pass metabolism, producing a slower and more gradual effect.

This gap is clinically significant. Cannabis edibles illustrate it clearly: the delayed onset leads some users to conclude the first dose has not worked and take more, resulting in inadvertent overdose. Similar dynamics appear with opioids, stimulants, and benzodiazepines, all of which show marked route-dependent differences in how quickly effects arrive and how intensely they build.

Substances with limited oral reuptake are sometimes taken by other routes precisely to increase the fraction that enters circulation — a pattern that carries higher dependence risk, since faster onset is associated with stronger reinforcement.